Hyponatremia Case Scenarios: Pathophysiology and Management
Case 1: Severe Symptomatic Hyponatremia with Seizures (Acute SIADH)
Clinical Presentation: A 40-year-old man presents with a generalized tonic-clonic seizure after 10-12 hours of police interrogation with fasting and marked psychological stress. Sodium is 121.6 mmol/L, serum osmolality 262 mOsm/kg, urine osmolality 540 mOsm/kg, urine sodium 48 mmol/L. Patient is euvolemic 1.
Pathophysiology: This represents a dual-hit mechanism: stress-induced non-osmotic AVP secretion (SIAD-like physiology) combined with low-solute intake ("beer-potomania" spectrum). The psychological stress triggers inappropriate antidiuresis despite hypotonic serum. Low dietary solute intake impairs free-water clearance, accelerating hyponatremia development. The rapid onset (<48 hours) causes acute cerebral edema leading to seizures 1.
Management: For severe symptoms (seizures, coma, altered mental status), immediately administer 3% hypertonic saline to correct 6 mmol/L over 6 hours or until severe symptoms resolve 2. Calculate sodium deficit: Desired increase (mmol/L) × 0.5 × ideal body weight (kg). Initial infusion rate = body weight (kg) × desired rate of increase (mmol/L/hour) 3.
Critical pitfall: This patient is at extremely high risk for autocorrection—a rapid, spontaneous rise in sodium once stress abates and solute intake resumes. Monitor sodium every 2-4 hours and be prepared to re-lower sodium with desmopressin or hypotonic fluids if correction exceeds 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 1. Total correction should not exceed 8 mmol/L in 24 hours or 18 mmol/L in 48 hours 2, 3.
Case 2: Post-Neurosurgical Hyponatremia (Cerebral Salt Wasting vs SIADH)
Clinical Presentation: A 55-year-old man develops hyponatremia (Na 118 mmol/L) 5 days after transsphenoidal pituitary tumor resection. He has mild nausea and headache. Urine osmolality is elevated at 450 mOsm/kg, urine sodium 85 mmol/L. Physical exam shows dry mucous membranes, decreased skin turgor, orthostatic hypotension 2.
Pathophysiology: Cerebral salt wasting (CSW) involves primary renal sodium loss leading to hypovolemia and secondary AVP release. The natriuretic peptides released from brain injury cause renal sodium wasting. Volume depletion triggers appropriate (not inappropriate) AVP secretion. This differs fundamentally from SIADH, where AVP release is inappropriate and patients are euvolemic or hypervolemic 2.
Distinguishing CSW from SIADH:
- CSW: Hypovolemic (orthostasis, dry mucous membranes, elevated BUN/Cr ratio), high urine sodium, responds to volume replacement
- SIADH: Euvolemic, high urine sodium, worsens with volume replacement 2
Management: CSW requires aggressive volume and sodium replacement—the opposite of SIADH management 2. For mild symptoms (Na 115-125 mmol/L):
- Transfer to intermediate care unit
- Normal saline IV at 100-150 mL/hour
- Oral sodium chloride 100 mEq TID
- Fludrocortisone 0.1 mg TID × 7 days to enhance renal sodium reabsorption 2
- Monitor sodium every 4 hours, daily weights, strict intake/output
Critical warning: Fluid restriction in CSW (mistaking it for SIADH) is catastrophic. In subarachnoid hemorrhage patients with CSW treated with fluid restriction, 21 of 26 developed cerebral infarction versus 19 of 90 normonatremic patients 2.
Case 3: Hypervolemic Hyponatremia in Cirrhosis with Ascites
Clinical Presentation: A 62-year-old man with decompensated cirrhosis presents with worsening ascites and peripheral edema. Sodium is 124 mmol/L. He is on furosemide 80 mg and spironolactone 200 mg daily. Exam shows massive ascites, 3+ pitting edema to thighs, elevated JVP. Urine sodium is 8 mmol/L 4.
Pathophysiology: Portal hypertension causes increased intrahepatic vascular resistance, triggering mesenteric and systemic vasodilation. The kidney perceives this as "effective" hypovolemia despite total body sodium and water overload. This activates the renin-angiotensin-aldosterone system and non-osmotic AVP release, causing water retention that exceeds sodium retention, resulting in dilutional hyponatremia 4.
Management: For outpatient asymptomatic hypervolemic hyponatremia in cirrhosis: implement both sodium restriction AND water restriction to 1-1.5 L daily fluid intake 4. Modify diuretics—consider reducing or temporarily holding them as they can worsen hyponatremia. Increase lactulose to promote solute-free water loss 4.
For severe or symptomatic hyponatremia (Na <120 mmol/L or symptoms):
- Admit for inpatient management
- Water restriction 1-1.5 L/day
- Discontinue diuretics temporarily
- IV albumin 20-25% based on volume assessment (6-8 g per liter of ascites removed if large-volume paracentesis >5L) 4
- Consider oral midodrine (vasoconstrictor therapy) to improve effective arterial blood volume 4
For refractory hyponatremia: Multidisciplinary approach including transplant team. Options include IV vasoconstrictors (terlipressin, norepinephrine), vaptans (vasopressin V2 receptor antagonists), hypertonic saline with extreme caution, or renal replacement therapy 4. Well-selected patients should be referred for TIPS (transjugular intrahepatic portosystemic shunt) 4.
Case 4: Chronic SIADH from Small Cell Lung Cancer
Clinical Presentation: A 68-year-old man with newly diagnosed small-cell lung cancer presents with confusion and falls. Sodium is 116 mmol/L. He is euvolemic on exam. Serum osmolality 245 mOsm/kg, urine osmolality 520 mOsm/kg, urine sodium 65 mmol/L. Thyroid and adrenal function normal 5.
Pathophysiology: Ectopic AVP production by tumor cells causes inappropriate water retention despite hypotonic serum. The collecting duct remains permeable to water due to persistent AVP action, preventing appropriate water diuresis. Patients maintain euvolemia through pressure natriuresis—increased sodium excretion compensates for volume expansion 5, 3.
Management: Chronic hyponatremia should NOT be rapidly corrected due to risk of osmotic demyelination syndrome 2. For asymptomatic or mildly symptomatic chronic SIADH:
First-line: Fluid restriction 1-1.5 L/day 2. If inadequate response after 48-72 hours, add:
- Oral sodium chloride 100 mEq TID
- High-protein diet (increases urea production, promoting water excretion)
- Consider loop diuretics (furosemide) with sodium supplementation to create dilute urine 2
For moderate symptoms or failed conservative management: Vasopressin receptor antagonists (vaptans—tolvaptan, conivaptan) provide prompt water diuresis and sodium correction in euvolemic hyponatremia 3. These are particularly useful when fluid restriction is impractical or ineffective.
For severe symptoms (confusion, seizures):
- ICU admission
- 3% hypertonic saline: correct 6 mmol/L over 6 hours until symptoms improve
- Then slow to <8 mmol/L total in 24 hours
- Monitor sodium every 2 hours initially 2
Palliative care consideration: In end-stage cancer, treatment priorities shift. If patient prioritizes comfort over sodium normalization, less aggressive fluid restriction may be appropriate, accepting mild chronic hyponatremia to improve quality of life 5.
Key Diagnostic Algorithm
Step 1: Assess symptom severity (seizures, coma = severe; nausea, confusion = mild; none = asymptomatic)
Step 2: Confirm hypotonic hyponatremia (serum osmolality <280 mOsm/kg). If normal/high osmolality, consider pseudohyponatremia (hyperglycemia, hyperlipidemia) 2.
Step 3: Determine volume status:
- Hypovolemic: Orthostasis, dry mucous membranes, low JVP → Check urine sodium
- Urine Na >40 mmol/L = renal loss (CSW, diuretics, adrenal insufficiency)
- Urine Na <20 mmol/L = extrarenal loss (vomiting, diarrhea)
- Euvolemic: Normal exam → SIADH (after excluding hypothyroidism, adrenal insufficiency)
- Hypervolemic: Edema, ascites, elevated JVP → Heart failure, cirrhosis, nephrotic syndrome 2
Step 4: Check urine osmolality:
100 mOsm/kg = inappropriate AVP action (SIADH, CSW, adrenal insufficiency)
- <100 mOsm/kg = appropriate water excretion (primary polydipsia, beer potomania) 2
Critical correction limits: Never exceed 8 mmol/L in 24 hours or 18 mmol/L in 48 hours to prevent osmotic demyelination syndrome 2, 3.